Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Inscripta Completes $20m Expansion Of Series C Financing, Increasing Total Round To $105.5M
Venture Capital

Inscripta Completes $20m Expansion Of Series C Financing, Increasing Total Round To $105.5M

by vcaonline.com posted 4months ago 17 views
Continued support of existing investors will fund commercialization efforts, product launch later this year BOULDER, Colo., April 4, 2019-- Inscripta, a leading gene editing technology company, today announced that it has increased its previously announced Series C financing with an additional $20 million from existing investors. The new funding adds to the $85.5 million financing Inscripta announced in 2018, bringing the total raised for the round to $105.5 million. “I would like to thank our investors for this expansion of our Series C round and their continued support and enthusiasm,” said Kevin Ness, CEO of Inscripta.

In this article